Order Article Reprints

Yadav VK, Huang Y-J, George TA, Wei P-L, Sumitra Mr, Ho C-L, Chang T-H, Wu ATH, Huang H-S. Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation. Cancers. 2020; 12(6):1590. https://doi.org/10.3390/cancers12061590

Yadav, Vijesh Kumar, Yan-Jiun Huang, Thomashire Anita George, Po-Li Wei, Maryam rachmawati Sumitra, Ching-Liang Ho, Tzu-Hao Chang, Alexander T. H. Wu, and Hsu-Shan Huang. 2020. "Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation" Cancers 12, no. 6: 1590. https://doi.org/10.3390/cancers12061590

Yadav, V. K., Huang, Y.-J., George, T. A., Wei, P.-L., Sumitra, M. r., Ho, C.-L., Chang, T.-H., Wu, A. T. H., & Huang, H.-S. (2020). Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation. Cancers, 12(6), 1590. https://doi.org/10.3390/cancers12061590